Emerald Health Therapeutics (CVE:EMH) Stock Price Down 3.8%

Emerald Health Therapeutics, Inc. (CVE:EMHGet Free Report) fell 3.8% on Tuesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Stock Down 3.8 %

The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The company’s fifty day moving average price is C$0.26 and its 200-day moving average price is C$0.26. The stock has a market capitalization of C$52.28 million and a PE ratio of -0.37.

Emerald Health Therapeutics Company Profile

(Get Free Report)

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.

See Also

Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.